New embolization treatment aims to ease knee pain without surgery

NCT ID NCT06930677

Recruiting now Symptom relief Sponsor: Next Biomedical Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new procedure called musculoskeletal embolization using NBGM200 to treat knee osteoarthritis. The goal is to reduce pain and improve function and quality of life. The trial will enroll 72 adults with knee OA confirmed by MRI. Participants will receive the embolization treatment and be followed for changes in pain and knee health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: embolization procedure using NBGM200
What this could lead to: If it works, this could offer a new, non-surgical option to reduce pain and improve knee function in people with knee osteoarthritis.
What could go wrong: This is an early, single-arm study with only 72 participants, so results may not apply to everyone. The procedure carries risks like infection or complications from embolization.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS (KNEE OA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis, knee

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KNEE OSTEOARTHRITIS (KNEE OA)

Contacts and locations

Locations

Elisabeth-Tweesteden Hospital
RECRUITING

Tilburg, Netherlands
University Hospital Ghent
RECRUITING

Ghent, Belgium
Uz Leuven
RECRUITING

Leuven, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.